期刊文献+

冠心病患者血浆纤维蛋白原与hs-CRP及血脂检测的临床意义 被引量:9

Clinical significance of detection of plasma fibrinogen and high sensitivity C-reactive protein in coronary heart disease
下载PDF
导出
摘要 目的探讨血浆纤维蛋白原(FIB)与超敏C反应蛋白(hs-CRP)、血脂在冠心病诊疗中的价值。方法回顾性分析我院收治的98例冠心病患者与60例正常人群的临床资料,比较两组中血浆FIB、hs-CRP以及血脂水平的差异,以及3者与冠心病严重程度的关系。结果冠心病组中LDL-C水平均高于正常组,差异有统计学意义(P<0.05)。冠心病组的急性心肌梗死(AMI)与不稳定性心绞痛(UAP)的FIB、hs-CRP水平均高于正常组,差异有统计学意义(P<0.05),稳定性心绞痛(SAP)与正常组差异无统计学意义(P>0.05)。与正常组相比较,血管病变支数越多,FIB、hs-CRP、LDL-C的水平越高,差异有统计学意义(P<0.05)。结论通过检测FIB、hs-CRP能够判断疾病严重程度,对诊断及预后判断有重要价值。 Objective To investigate the value of detection of plasma fibrinogen (FIB) and high sensitivity C-reactive protein (hs-CRP) in coronary heart disease. Methods Detected the levels of the FIB and hs-CRP of 98 cases with coronary heart disease and 60 cases of normal physical examination in our hospital, and analyzed the relationship among the FIB, hs- CRP expressions and the seriousness of coronary heart disease. Results The LDL-C level of coronary heart disease group was significantly higher than that of the control group (P〈0.05). The FIB and hs-CRP levels of acute myocardial infarction (AMI) and unstable angina pectoris (UAP) in CHD group were significantly higher than that of the control group (P〈0.05) ; these fig- ures were no difference in unstable angina(SAP) compared to the control group(P〉0.05); compared to the control group, FIB and higher hs-CRP levels were significantly higher in multi-vessel disease (P〈0.05). Conclusion The detection of FIB and hs-CRP levels can judge the seriousness of the disease, and is valuable for diagnosis and prognosis.
出处 《中国现代医药杂志》 2013年第9期30-32,共3页 Modern Medicine Journal of China
关键词 冠心病 血浆纤维蛋白原 超敏C反应蛋白 血脂 Coronary heart disease Plasma fibrinogen High sensitivity C-reactive protein Blood liquid
  • 相关文献

参考文献4

二级参考文献14

  • 1刘东,临床心血管病杂志,2000年,16卷,64页
  • 2Benderly M, Graft E, Reicher RH. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. Arterioseler Thromb Vase Biol,1996,3:351-356.
  • 3Castelli WP. Lipids, risk factors and ischaemic heart disease.Atherosclerosis, 1996,124 :S1-S9.
  • 4Folsom AR. " New" risk factors for atherosclerotic diseases. Exp Gerontol Experimental Gerontology, 1999,34:483.
  • 5Behague I, Poirier O, Nicaud V, et al. βfibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study.Circulation, 1996,93:440-449.
  • 6Gensini GF, Comeglio M, Colella A. Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J,1998,19 :A53- A61.
  • 7Eriksson M,Egberg N,Wamala S,et al. Relationship between plasma fibrinogen and coronary heart disease in women. Arterioscler Thromb Vasc Biol, 1999,19:67-72.
  • 8BECKER RC,CANNON CP,BOVILL EG,et al.Prognostic Value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction[J].Am J Cardiol,1996,78(2):142-147.
  • 9ERUST E.RESCH KL.Fibrincugess as a cardiovascular risk factor:A meta-analysis and review of the literature[J].Am Intern Med,1993,118(8):956 -963.
  • 10DI NAPOLI P,TACCARDI AA,OLIVER M,et al.Station and stroke:evidence for cholesterol-independent[J].Eur Heart J,2002,23 (24):1908-1921.

共引文献102

同被引文献102

引证文献9

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部